Cambridge Investment Research Advisors, Inc. Renalytix PLC Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Renalytix PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 14,500 shares of RNLX stock, worth $2,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,500Holding current value
$2,175% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RNLX
# of Institutions
31Shares Held
3.78MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD847KShares$126,9800.0% of portfolio
-
Stifel Financial Corp St. Louis, MO561KShares$84,1500.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY555KShares$83,2500.01% of portfolio
-
Tejara Capital LTD London, X0500KShares$75,0590.04% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$50,3270.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $5.62M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...